Inhalation Sciences and Karolinska Institutet renew partnership with new validation work and Mars dust study
(Stockholm, Sweden, 12 October 2021) In a renewed partnership Karolinska Institutet (KI) in Stockholm will help validate ISAB’s new XposeALI® MP (Micro Perfusion) tool, including using it to test a Mars dust surrogate for the European Space Agency as part of exploring future manned missions to Mars. XposeALI® MP is a highly automated new iteration of ISAB’s current cell culturing module and is expected to make in vitro lung studies simpler, more consistent and more cost-effective – including for biologics, a key priority area for inhaled drug developers.On Friday 8 October ISAB renewed its